Assessment of the Neutrophil Dominating Protein Calprotectin in Feces: A Methodologic Study

References

• Best WR, Becktel JB, Singleton JW, Kern F, Jr. Development of a Crohn's disease activity index. Gastroenterology 1976; 70: 439–44
   PubMed Web of Science ®Google Scholar
• Van Hees PAM, Van Elteren PH, Van Lier HJJ, Van Tongeren JHM. An index of inflammatory activity in patients with Crohn's disease. Gut 1980; 21: 279–86
   PubMed Web of Science ®Google Scholar
• Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980; 1: 514
   PubMed Web of Science ®Google Scholar
• Meyers S, Wolke A, Field SP, Feuer EJ, Johnson JW, Janowitz HD. Fecal â-antitrypsin measurements: an indicator of Crohn's disease activity. Gastroenterology 1985; 89: 13–8
   PubMed Web of Science ®Google Scholar
• Karbach U, Ewe K, Bodenstein H. ovantitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease. Gut 1983; 24: 718–23
   PubMed Web of Science ®Google Scholar
• Grill BB, Hillemeier AC, Gryboski JD. Fecal â-aniitrypsin clearance in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1984; 3: 56–61
   PubMedGoogle Scholar
• Thomas DW, Sinatra FR, Merritt RJ. Random fecal avantitrypsin concentration in children with gastrointestinal disease. Gastroenterology 1981; 80: 776–82
   PubMed Web of Science ®Google Scholar
• Segal AW, Munro JM, Ensell J, Sarner M. 111Indium tagged leukocytes in the diagnosis of inflammatory bowel disease. Lancet 1981; 2: 230–1
   PubMed Web of Science ®Google Scholar
• Saverymuttu SH, Peters AM, Hodgson HJ, Chadwick VS, Lavender JP. 111'Indium leukocyte scanning in a small-bowel Crohn's disease. Gastrointest Radiol 1983; 8: 157–61
   PubMedGoogle Scholar
• Saverymuttu SH. Clinical remission in Crohn's disease-assessment using faecal 111In granulocyte excretion. Digestion 1986; 33: 74–9
   PubMed Web of Science ®Google Scholar
• Park RHR, McKillop JH, Duncan A, MacKenzie JF, Russel RI. Can 111indium autologous mixed leukocyte scanning accurately assess disease extent and activity in Crohn's disease?. Gut 1988; 29: 821–5
   PubMedGoogle Scholar
• Pullman WE, Sullivan PJ, Barratt PJ, Lising J, Booth JA, Doe WF. Assessment of inflammatory bowel disease activity by 99mtechnetium phagocyte scanning. Gastroenterology 1988; 95: 989–96
   PubMed Web of Science ®Google Scholar
• Nelson RL, Subramanian K, Gasparaitis A, Abcarian H, Pavel DG. 111Indium labelled granulocyte scan in the diagnosis and management of acute inflammatory bowel disease. Dis Colon Rectum 1990; 33: 451–7
   PubMed Web of Science ®Google Scholar
• Bohbouth GE. General discussion. Activity related abnormalities in inflammatory bowel disease, GE. Bohbouth. University Hospital, LeidenThe Netherlands 1988; 105–14
   Google Scholar
• Bruce B, Craig Hillemeier A, Grybosky JD. Fecal avantitrypsin clearance in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1984; 3: 56–61
   PubMedGoogle Scholar
• Catassi C, Cardinali E, ďAngelo G, Coppa GV, Giorgi PL. Reliability of random fecal â-antitrypsin determination on non-dried stools. J Pediatr 1986; 109: 500–2
   PubMedGoogle Scholar
• Becker W, Fischbach W, Weppler M, Mosl B, Jacoby G, Börner W. Radiolabeled granulocytes in inflammatory bowel disease:diagnostic possibilities and clinical indications. Nucl Med Com-mun 1988; 9: 693–701
   PubMed Web of Science ®Google Scholar
• Becker W, Schomann E, Fischbach W, Borner W, Gruner KR. Comparison of 99mTc-HMPOA and 111In-oxine labelled granulocytes in man: first clinical results. Nucl Med Commun 1988; 9: 435–47
   PubMed Web of Science ®Google Scholar
• Buxton-Thomas MS, Dickinson RJ, Maltby P, Hunter JO, Wraight EP. Evaluation of indium scintigraphy in patients with active inflammatory bowel disease. Gut 1984; 2: 1372–5
   Google Scholar
• Crama-Bohbouth GE, Arndt JW, Pena AS, et al. Value of111 Indium granulocyte scintigraphy in the assessment of Crohn's disease of the small intestine: prospective investigation. Digestion 1988; 40: 227–36
   PubMed Web of Science ®Google Scholar
• Schölmerich J, Schmidt E, Schümichen C, Billmann P, Schmidt H, Gerok W. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using 99mTc-hexamethyl propylene amine oxine as leukocyte label. Gastroenterology 1988; 95: 1287–93
   PubMed Web of Science ®Google Scholar
• Arndt JW, Crama-Bohbouth GE, Verspaget HW, et al. Image quality and radiopharmaceutical parameters of 111Indium granulocytes in scintigraphy of inflammatory bowel disease. Eur J Nucl Med 1989; 15: 197–200
   PubMedGoogle Scholar
• Kordossis T, Joseph AEA, Gane JN, Bridges CE, Griffin GE. Fecal leukocytosis, 111Indium labelled autologous polymorphonuclear leukocyte abdominal scanning, and quantitative fecal 111indium excretion in acute gastroenteritis and entero-pathogen carriage. Dig Dis Sci 1988; 33: 1383–90
   PubMedGoogle Scholar
• Dale I, Brandtzaeg P, Fagerhol MK, Scott H. Distribution of a new myelomonocytic antigen (L-l) in human peripheral blood leukocytes. Am J Clin Pathol 1985; 84: 24–34
   PubMed Web of Science ®Google Scholar
• Fagerhol MK, Andersson KB, Naess-Andresen CF, Brandtzaeg P, Dale I. Calprotectin (the LI leukocyte protein). Dedman Stimulus response coupling: the role of intracellular calcium-binding proteins, L Vana, JR Smith. CRC Press Inc, Boca Raton, Fla. 1990; 187–210
   Google Scholar
• Dale I, Fagerhol MK, Naesgaard I. Purification and partial characterization of a highly immunogenic human leukocyte protein, the L-l antigen. Eur. J Biochem 1983; 134: 1–6
   Google Scholar
• Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial action of calcium binding leukocyte L-l protein, calprotectin. Lancet 1990; 336: 763–5
   PubMed Web of Science ®Google Scholar
• Berntzen HB, Munthc E, Fagerhol MK. The major granulocyte protein LI as an indicator of inflammatory joint disease. Scand J Rheumatol 1988; 251–6, Suppl 76
   Google Scholar
• Røseth AG, Aadland E, Schjønsby H, Fagerhol MK, Vatn M. Fecal calprotectin: a new marker of disease activity in IBD? [abstract]. Scand J Gastroenterol 1990; 25(24)
   Google Scholar
• Fliedner SH, Cronkite EP, Robertson JS. Granulopoiesis, senescence and random loss of neutrophilic granulocytes in human beings. Blood 1964; 91: 404–14, Suppl 176
   Google Scholar
• Crossley JR, Elliott RB. Simple method for diagnostic protein-losing enteropathies. Br Med J 1977; 1: 428–9
   PubMed Web of Science ®Google Scholar
• Loftus B, Loh LC, Henry K, Leader M. Mac387: its non-specificity as a tumour marker or maker of histiocytes. Hi-stopathology 1991; 19: 251–5
   PubMedGoogle Scholar
• Dale I, Brandtzaeg P. Expression of the epithelial LI antigen as an immunohistochemical marker of squamous cell carcinoma of the lung. Histopathology 1989; 14: 493–502
   PubMed Web of Science ®Google Scholar
• Tungekar MF, Heryet A, Gatter KC. The LI antigen and squamous metaplasia in the bladder. Histopathology 1991; 19: 245–50
   PubMedGoogle Scholar